Maxim Group
http://www.maximgrp.com/Maxim Group is a financial services firm that provides investment banking, asset management, research, and sales & trading to a diverse range of corporate clients, institutional investors and high net worth individuals.
The firm’s research division uses fundamental research and a “bottom up” approach to making investment recommendations. Maxim’s research analysts focus on under-covered, small- to mid-cap names in a variety of sectors including healthcare, technology, retail and others.
View Older Stories View More Recent Stories
-
NovaBay Announces $6.86 Million “At Market” Private Placement
-
AmbiCom Holdings, Inc. Announces Engagement of Investment Banking Firm Maxim Group LLC to Provide Strategic Advisory Services
-
IsoRay (ISR) Results 'Exceptional', Maxim Group Says; Reiterates Buy Rating, $5 PT
-
Maxim Still Bullish on IsoRay (ISR) Following Q1 Results; More Physicians Adopting Cesium-131
-
Concept Capital Markets adds trading and client support personnel
-
Gladstone Investment Corporation Announces Closing of Offering of 1,610,000 Shares of Its 6.50% Series C Cumulative Term Preferred Stock for Gross Proceeds of Approximately $40.3 Million
-
Gladstone Land (LAND) Prices Larger 1.25M Common Offering at $11.40/Share
-
Gladstone Land Corporation Prices Common Stock Offering
-
Gladstone Land Corporation Prices Common Stock Offering
-
Maxim Group Maintains Hold Leading up to Urban Outfitters (URBN) Q1 Release
-
Pre-Open Stock Movers 05/13: (WPZ) (HDP) (PLL) Higher; (OREX) (VSLR) (DD) Lower (more...)
-
Maxim Group Upgrades PowerSecure (POWR) to Buy
-
Gladstone Land (LAND) Announces 1.1M Common Stock Offering
-
Gladstone Land Corporation Announces Common Stock Offering
-
Gladstone Land Corporation Announces Common Stock Offering
-
Hemisphere Media (HMTV) Prices 3.2M Common Secondary Offering at $12/Share
-
Hemisphere Media Group Announces Pricing of Secondary Public Offering
-
Gladstone Investment Corporation Prices Preferred Stock Offering
-
Gladstone Investment Corporation Prices Preferred Stock Offering
-
Harris & Harris Group Portfolio Company OpGen Raises $17.1 Million in Initial Public Offering
-
Harris & Harris Group Portfolio Company OpGen Raises $17.1 Million in Initial Public Offering
-
Inovio Pharma (INO) Closes 9.5M Common Offering for Net Proceeds of $82M
-
Inovio Pharmaceuticals Closes $87.4 Million Underwritten Financing
-
Inovio Pharmaceuticals Closes $87.4 Million Underwritten Financing
-
OpGen (OPGN) IPO Opens Lower
-
Gladstone Investment Corporation Launches New Term Preferred Stock Offering
-
Gladstone Investment Corporation Launches New Term Preferred Stock Offering
-
Cytori Therapeutics (CYTX) Prices Direct Offering at 77c/Unit
-
Cytori Prices Registered Direct Offering Providing for up to $25 million in Equity Financing
-
OpGen (OPGN) Prices IPO at $6/Unit
-
OpGen Announces Pricing of Initial Public Offering
-
Hemisphere Media Group Announces Launch of Secondary Public Offering
-
BioLineRx (BLRX) Bullish Stance Reiterated at Maxim Group After Entering Expansion stage of AML Phase 2 Study
-
Maxim Group Downgrades iGATE (IGTE) to Hold
-
Notable Analyst Rating Changes 4/30: (JBLU) (MDLZ) (PGR) Upgraded; (PAG) (BBVA) (OI) Downgraded
-
Inovio Pharma (INO) Prices 9.5M Common Offering at $8/Share
-
Inovio Pharmaceuticals Announces Pricing of Public Offering of Common Stock
-
Maxim Group Assumes NovaBay Pharmaceuticals (NBY) at Buy
-
StemCells, Inc. Announces Closing of $25 Million Public Offering
-
Maxim Group Starts RestorGenex (RESX) at Buy
-
Maxim Group Upgrades First Internet Bancorp (INBK) to Buy
-
StemCells (STEM) Prices Common, Warrants Offering at $0.70/Unit
-
StemCells, Inc. Announces Pricing of Public Offering to Raise $25 Million
-
StemCells, Inc. Announces Pricing of Public Offering to Raise $25 Million
-
StemCells (STEM) Falls on Plan to Offer Common Stock and Warrants
-
Maxim Group Starts Radius Health (RDUS) at Buy
-
LookSmart Announces Spin-Off and Definitive Merger Agreement with Pyxis
-
StemCells, Inc. Announces Proposed Public Offering of Common Stock and Warrants
-
StemCells, Inc. Announces Proposed Public Offering of Common Stock and Warrants
-
Cytori Therapeutics (CYTX) a Step Closer to Clinical Trials, Maxim Group Notes

